JANE DAVIS: Open Payments
NPI 1780778480 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$698 in 25 payments from 8 companies in 2025. Trend: 2023 $804 · 2024 $692 · 2025 $698
Food & beverage: $698
| Company | Payments | Amount |
|---|---|---|
| Fresenius USA Marketing, Inc. | 17 | $241 |
| Novartis Pharmaceuticals Corporation | 2 | $125 |
| AKEBIA THERAPEUTICS INC | 1 | $103 |
| Travere Therapeutics, Inc. | 1 | $101 |
| Vantive US Healthcare LLC | 1 | $38 |
| Vifor Pharma, Inc. | 1 | $33 |
| Calliditas Therapeutics US Inc. | 1 | $33 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $23 |
Products named: VELPHORO, Vanrafia, Vafseo, Renal - PD, Veltassa, TARPEYO, Tryvio.
Industry payments across AL — which companies pay providers there.
